CGAS and breast carcinoma: For example, the breast cancer cell line MDA-MB-231 has a functional cGAS-STING axis, but pathway activation does not yield a type I IFN response or any other immune signaling, which suggests that cancer cells have inactivated the signaling route more downstream [27].